Application of dehydroeffusol in preparation of drugs for tumor preventing and tumor angiogenesis inhibiting, health food or cosmetics
A technology of tumor angiogenesis and tumor angiogenesis, applied in anti-tumor drugs, cosmetic preparations, applications, etc., can solve the problem of small effect and achieve the effect of strong specific inhibitory effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0047] The preparation of embodiment 1 dehydrofurfol
[0048] The dried rushes are crushed, extracted with ethanol, and the alcohol solution is concentrated under reduced pressure until there is no alcohol smell. The sample is loaded on a macroporous resin column, eluted with water and ethanol, and the eluted part of 85% ethanol is collected, and recovered to dryness under reduced pressure. Mix the sample with silica gel, load the sample on a silica gel column, detect and enrich the fraction by thin layer chromatography (TLC) to obtain the crude product of dehydroephedrine. The crude product of dehydrobutadiene is separated and purified repeatedly through silica gel column etc. to obtain the pure product of dehydrobutadiol (purity>90%), and then further purified by preparative HPLC, the purity of which reaches more than 95%. For the chemical structure and molecular formula of dehydroeufenol, see figure 1 .
Embodiment 2
[0049] Example 2 The effect of dehydrourban on the proliferation of various tumor cells / tumor stem cells:
[0050] 1. Name of tumor cell lines (62 strains)
[0051] Human megakaryoblastic leukemia cells MEG-01, Dami and Daudi, human chronic myelogenous leukemia cells PBL985 and K562, human myeloid leukemia cells HL-60, human leukemia cell line NB-4, human erythroid leukemia cells HEL, human Monocytic leukemia cells THP-1, UC-CUC, SHI-1 and SHI-2, human Burkitt's lymphoma cells Raji, Namalva, human T lymphocytic leukemia cells Jurkat, human T lymphocyte line H9, human acute lymphoma Cell leukemia T lymphocyte CCRF, human myeloma cell lines 8226, My-5, opm2, KMS11 and LP-1, human osteosarcoma cells Saos-2, MG-63, U-2OS and SW1353, human glioma stem cell line SU2 , human glioma cells SHG44, U251, A172 and U-87MG, human umbilical vein endothelial cells Eahy926, human umbilical vein endothelial cells ECV-304, human lung microvascular endothelial cells HLMVEC, human ovarian cancer ...
Embodiment 3
[0067] Example 3 Effects of Dehydroufen on Proliferation of Multiple Gastric Cancer Cells and Normal Gastric Epithelial Cells
[0068] 1. Cell lines: human gastric cancer cells SGC-7901, AGS and MGC803, human normal gastric mucosal epithelial cells GES-1.
[0069] 2. The drug under test: dehydroeufen, dissolved in dimethyl sulfoxide (DMSO), diluted to the desired concentration with RPMI 1640 or DMEM (high sugar) medium.
[0070] 3, experimental method: with embodiment 2
[0071] 4. Experimental results: dehydroeufenol showed a good proliferation inhibitory effect on a variety of gastric cancer cells, and with the increase of drug concentration, the inhibitory effect on the proliferation of various gastric cancer cells was correspondingly enhanced. The half-inhibitory concentrations of three kinds of gastric cancer cells SGC-7901, AGS and MGC803 were about 4.86, 8.47 and 4.17 μg / ml respectively; at the same time, dehydroeufen had only a relatively high concentration on normal ...
PUM
Property | Measurement | Unit |
---|---|---|
weight | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com